You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Drotrecogin Alfa (Activated) in Adults with Septic Shock
|
|---|---|
| Published in |
New England Journal of Medicine, May 2012
|
| DOI | 10.1056/nejmoa1202290 |
| Pubmed ID | |
| Authors |
V Marco Ranieri, B Taylor Thompson, Philip S Barie, Jean-François Dhainaut, Ivor S Douglas, Simon Finfer, Bengt Gårdlund, John C Marshall, Andrew Rhodes, Antonio Artigas, Didier Payen, Jyrki Tenhunen, Hussein R Al-Khalidi, Vivian Thompson, Jonathan Janes, William L Macias, Burkhard Vangerow, Mark D Williams |
| Abstract |
There have been conflicting reports on the efficacy of recombinant human activated protein C, or drotrecogin alfa (activated) (DrotAA), for the treatment of patients with septic shock. |
X Demographics
The data shown below were collected from the profiles of 104 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 18 | 17% |
| United Kingdom | 15 | 14% |
| France | 6 | 6% |
| Mexico | 4 | 4% |
| Spain | 3 | 3% |
| Australia | 3 | 3% |
| Colombia | 2 | 2% |
| Sweden | 1 | <1% |
| Brazil | 1 | <1% |
| Other | 11 | 11% |
| Unknown | 40 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 69 | 66% |
| Practitioners (doctors, other healthcare professionals) | 21 | 20% |
| Scientists | 9 | 9% |
| Science communicators (journalists, bloggers, editors) | 5 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 657 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | <1% |
| Italy | 4 | <1% |
| Brazil | 3 | <1% |
| France | 3 | <1% |
| Colombia | 2 | <1% |
| Australia | 2 | <1% |
| Spain | 2 | <1% |
| United Kingdom | 2 | <1% |
| Canada | 2 | <1% |
| Other | 9 | 1% |
| Unknown | 624 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 105 | 16% |
| Other | 78 | 12% |
| Student > Ph. D. Student | 75 | 11% |
| Professor > Associate Professor | 58 | 9% |
| Student > Master | 56 | 9% |
| Other | 192 | 29% |
| Unknown | 93 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 375 | 57% |
| Agricultural and Biological Sciences | 63 | 10% |
| Biochemistry, Genetics and Molecular Biology | 33 | 5% |
| Immunology and Microbiology | 18 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 2% |
| Other | 45 | 7% |
| Unknown | 113 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 135. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2024.
All research outputs
#314,215
of 25,734,859 outputs
Outputs from New England Journal of Medicine
#5,081
of 32,654 outputs
Outputs of similar age
#1,380
of 178,284 outputs
Outputs of similar age from New England Journal of Medicine
#37
of 268 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,654 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,284 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 268 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.